DLL3 as a potential diagnostic and therapeutic target in neuroendocrine neoplasms: A narrative reviewAnnarita Peddio, Alberto Servetto, Erica Pietroluongo et al.|Critical Reviews in Oncology/Hematology|2024Cited by 25
Assessment of Total, PTEN–, and AR-V7+ Circulating Tumor Cell Count by Flow Cytometry in Patients with Metastatic Castration-Resistant Prostate Cancer Receiving EnzalutamideGiuseppe Di Lorenzo, Carlo Buonerba, Franco Morelli et al.|Clinical Genitourinary Cancer|2021Cited by 23
Immunological signature of patients with thymic epithelial tumors and Good syndromeAnna Maria Malfitano, Pietro Formisano, Vittoria D’Esposito et al.|Frontiers in Immunology|2022Cited by 16
Optimising triage procedures for patients with cancer needing active anticancer treatment in the COVID-19 eraGrazia Arpino, Sabino De Placido, Carmine De Angelis et al.|ESMO Open|2020Cited by 15
miRNAs in the Box: Potential Diagnostic Role for Extracellular Vesicle-Packaged miRNA-27a and miRNA-128 in Breast CancerCinzia Giordano, Stefania Catalano, Felice Maria Accattatis et al.|International Journal of Molecular Sciences|2023Cited by 15